Lactobacillus reuteri DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Atopic Dermatitis (AD) is a chronically relapsing skin condition characterized by dry, itchy, and inflamed skin where sufferers can frequently be subject to infections. Probiotics are known to be potent immune-modulators, and live Lactobacillus reuteri DSM 17938 has shown to be anti-inflammatory but also to possess antimicrobial and barrier function properties. This study aimed to investigate and compare two investigational ointment products (topical probiotic and control) for cutaneous acceptability, safety, and efficacy under normal conditions of use, in adult subjects with atopic dermatitis. The products were applied twice daily for 8 weeks, and cutaneous acceptability, SCORAD index, local SCORAD, and adverse events were evaluated after 4 and 8 weeks of treatment. At the end of the observations, it was demonstrated that both the probiotic-containing and probiotic-free ointments were both cutaneously acceptable and safe. It importantly showed a statistically and clinically significant improvement of the SCORAD index and local SCORAD in adult subjects with AD after 4 and 8 weeks of continuous use. In conclusion, we show evidence that the probiotic product, containing live L. reuteri DSM 17938 as an extra ingredient, is safe and promising as a novel topical cosmetic ointment and with further testing could be a standard topical product for the management of atopic dermatitis or other disorders associated with the skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808
Nakatsuji, T., Chen, T. H., Narala, S., Chun, K. A., Two, A. M., Yun, T., Shafiq, F., Kotol, P. F., Bouslimani, A., Melnik, A. V., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4680 · Cited by 1,095
Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010070 · Cited by 759 · cited 3×
“In the case of topical products, the product must be suitable for use on the skin; therefore it is important to understand that the control product, in this case, is an effective product in itself in the management of AD, Table A1 (Appendix A), as it contains other barrier protecting ingredients, like shea butter [17,…”
BackgroundEmollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H. I., Brown, S. J., Chen, Z., Chen, Y., & Williams, H. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.005 · Cited by 722
Dupilumab: A review of its use in the treatment of atopic dermatitis
Gooderham, M. J., Hong, H. C.-H., Eshtiaghi, P., & Papp, K. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.12.022 · Cited by 343
Schaefer, L., Auchtung, T. A., Hermans, K. E., Whitehead, D., Borhan, B., & Britton, R. A. (2010) · Microbiology · doi:10.1099/mic.0.035642-0 · Cited by 310 · cited 2×
“It is capable of producing antimicrobial substances, such as reuterin, which inhibits both Gram-positive and Gram-negative bacteria [35,36], as well as suppressing relevant pathogens [26,37].”
BackgroundPerez‐Burgos, A., Wang, L., McVey Neufeld, K., Mao, Y., Ahmadzai, M., Janssen, L. J., Stanisz, A. M., Bienenstock, J., & Kunze, W. A. (2015) · The Journal of Physiology · doi:10.1113/jp270229 · Cited by 123 · cited 1×
“They have recently been shown to interact with pain receptors such as TRPV1 receptor in the gut [54].”
BackgroundPrince of Wales Hospital, T. C. U. O. H. K., Hon, K., Tsang, Y., Pong, N., Lee, V. W., Luk, N., Chow, C., & Leung, T. (2015) · Hong Kong Medical Journal · doi:10.12809/hkmj144472 · Cited by 32 · cited 2×
“In the case of topical products, the product must be suitable for use on the skin; therefore it is important to understand that the control product, in this case, is an effective product in itself in the management of AD, Table A1 (Appendix A), as it contains other barrier protecting ingredients, like shea butter [17,…”
Background
Cited by
Human Skin Microbiome: Impact of Intrinsic and Extrinsic Factors on Skin Microbiota
Skowron, K., Bauza-Kaszewska, J., Kraszewska, Z., Wiktorczyk-Kapischke, N., Grudlewska-Buda, K., Kwiecińska-Piróg, J., Wałecka-Zacharska, E., Radtke, L., & Gospodarek-Komkowska, E. (2021) · Microorganisms · doi:10.3390/microorganisms9030543 · Cited by 345
Skin Barrier Function and the Microbiome
Lee, H.-J., & Kim, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113071 · Cited by 317
“The strains tested in these studies are Vitreoscilla filiformis [83], Aquaphilus dolomiae [84], Lactobacillus reuteri [85], and Roseomonas mucosa [86]; these species increase the proportion of CoNS in the skin and inhibit colonization by S.”
BackgroundMachado, P., Ribeiro, F. N., Giublin, F. C. W., Mieres, N. G., Tonin, F. S., Pontarolo, R., Sari, M. H. M., Lazo, R. E. L., & Ferreira, L. M. (2025) · Pharmaceuticals · doi:10.3390/ph18050704 · Cited by 44
Greenzaid, J. D., Chan, L. J., Chandani, B. M., Kiritsis, N. R., & Feldman, S. R. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2326625 · Cited by 17
“The most commonly studied topical probiotics include Lactobacilli [45,46,48,52] and Bifidobacterium [45,48], which reduced SCORAD indices and S. aureus load from baseline and versus control groups.”
BackgroundJeznienė, S., Mikalauskienė, E., Jekabsone, A., & Šipailienė, A. (2025) · Pharmaceuticals · doi:10.3390/ph19010066
Metadata
- Authors
- Butler, É., Lundqvist, C., & Axelsson, J.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2020-07-11
- Volume
- 8
- Issue
- 7
- Pages
- 1026
- ISSN
- 2076-2607 (ISSN-L)
- OpenAlex
- W3041229892
- Cited by
- 84
- References
- 11
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.